Abiopharma

argenx to Host Autoimmune Myositis R&D Webinar

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

argenx to Host Autoimmune Myositis R&D Webinar

Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Albertsons Media Collective Brings Sponsored Product Discovery to AI-Powered Conversational Search

Communiqué de presse : Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes

Dormant shares - change in the number of shares

General Announcement: CLARIFICATION ANNOUNCEMENT- Expiry of warrants on 29 June 2026 & 01 July 2026

General Announcement: Net Asset Value ("NAV") as of 22 June 2026

General Announcement: Press Release-Trek advances deployment of AI Renewable Solutions with projects in Cambodia